Cite
HARVARD Citation
Schem, C. et al. (n.d.). Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5‐Fluorodeoxyuridine‐Alendronate in a Preclinical Model of Breast Cancer Bone Metastases. Journal of bone and mineral research. pp. 536-548. [Online].